BiPar Sciences, Inc.
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Jul 18, 2006 → Nov 11, 2008 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7405227B2 | Treatment of cancer | Human Necessities | 26 | Active |
| US7732491B2 | Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents | Human Necessities | 25 | Active |
| US7538252B2 | Drug design for tubulin inhibitors, compositions, and methods of treatment thereof | Physics | 8 | Active |
| US7994222B2 | Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds | Human Necessities | 5 | Active |
| US8377985B2 | Treatment of cancer | Human Necessities | 4 | Active |
| US8143447B2 | Treatment of cancer | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.